Akshaya Raman on ‘The Ivory Key’ & Representation

American writer Akshaya Raman has published her thrilling debut book, The Ivory Key. Released in January 2022, the book is an Indian-inspired fantasy that takes you on a gripping journey filled with peace, war and magic. The story surrounds four siblings who are on a quest to find The Ivory Key, a rumoured new source of magic. However, in order […]

Update on the phase IV confirmatory study of Aduhelm for Alzheimer’s disease – Biogen + Eisai

Biogen Inc. and Eisai Co., Ltd. provided an important update on the continuing progress of the Phase IV post-marketing confirmatory study of Aduhelm (aducanumab-avwa) 100 mg/mL injection for intravenous use in Alzheimer’s disease. The companies anticipate submitting the final protocol for review to the FDA in March 2022, with the initiation of patient screening in May 2022. The study is […]

Newly-wed Mouni Roy looks Exquisite in Gold Lehenga

She called him her “everything”. Newly-wed Mouni Roy took to Instagram to share pictures from her wedding sangeet. The actress wore a gold and beige lehenga by Falguni Shane Peacock for the occasion. Mouni Roy and Suraj Nambiar got married in an intimate ceremony at the Hilton Goa Resort on January 27, 2022. The couple tied the knot in the […]

AbbVie provides update on Rinvoq for the treatment of rheumatoid arthritis in the U.S

AbbVie announced an update to the U.S. Prescribing Information and Medication Guide for Rinvoq (upadacitinib) for the treatment of adults with moderate to severe rheumatoid arthritis (RA). This update follows a Drug Safety Communication (DSC) issued on 1 September, 2021 by the FDA following its final review of the post-marketing study, ORAL Surveillance, evaluating Xeljanz (tofacitinib) in patients with RA. […]

Gippy Grewal denied Entry to Pakistan

The Indian immigration authorities reportedly stopped Gippy Grewal from entering Pakistan through the Wagah border on January 28, 2022. According to sources from the Evacuee Propriety Trust Board (EPTB), arrangements were in place to receive the Punjabi singer at the border as he was scheduled to visit Kartarpur. An EPTB official said: “He was to move to Kartarpur at 9:30 […]

European Commission approves Lenvima + Keytruda to treat endometrial carcinoma – Eisai + Merck Inc.

Eisai Co., Ltd. and Merck Inc., announced that the European Commission has approved the combination of Lenvima, the orally available multiple receptor tyrosine kinase inhibitor discovered by Eisai, plus Keytruda, the anti-PD-1 therapy from Merck Inc., for the treatment of advanced or recurrent endometrial carcinoma in adults who have disease progression on or following prior treatment with a platinum-containing therapy […]

Bhumi Pednekar says Badhaai Do is a “Sensitive” Film

Bhumi Pednekar says her upcoming film Badhaai Do explores “love and acceptance” sensitively, never using its humour against the LGBTQI community for cheap laughs. The film features Bhumi Pednekar as a lesbian physical education teacher who ties the knot with a gay policeman, played by Rajkummar Rao. Badhaai Do is the sequel to the 2018 hit film Badhaai Ho. Bhumi […]

Nanoparticle-formulated drug combination is effective in medulloblastoma, a pediatric brain tumor

UNC Lineberger Comprehensive Cancer Center researchers have demonstrated that a novel combination of two drugs that act as targeted inhibitors, delivered in a nanoparticle formulation, extend the survival of mice with medulloblastoma. The research team believes this laboratory success could be translated into a less toxic treatment for medulloblastoma, the most common malignant pediatric brain tumor. Advances such as this […]

Gajjan Singh on Punjabi Folk Trap Music & ‘Comin’ Home’

Canada’s Punjabi folk trap artist, Gajjan Singh, has once again proved his musical capabilities with his new track, ‘Comin’ Home’. Released on January 21, 2022, the incredible song was collectively created by Gajjan and fellow musicians, Malcolm Flex and IQ Singh. Described as the first Punjabi folk trap artist, ‘Comin’ Home’ certainly oozes with these unique qualities. Mixing the rawness […]

INTRIGUE Phase III study of Qinlock fails to meet primary endpoint in gastrointestinal stromal tumor – Deciphera Pharmaceuticals

Deciphera Pharmaceuticals announced top-line results from the INTRIGUE Phase III clinical study of Qinlock (ripretinib) in patients with gastrointestinal stromal tumor (GIST) previously treated with imatinib. The study did not meet the primary endpoint of improved progression-free survival (PFS) compared with the standard of care. In the study, 453 patients were randomized 1:1 to either Qinlock 150 mg once daily […]